Latest Advances

  • Condition: Children and Adolescents with Prader-Willi Syndrome (PWS)
  • Journal: Nutrients
  • Treatment Used: Bifidobacterium Animalis Subsp. Lactis Strain (BPL1)
  • Number of Patients: 39
  • Published —
This study evaluated Bifidobacterium animalis subsp. lactis strain (BPL1) in children and adolescents with Prader-Willi syndrome (PWS), a rare genetic disorder.
  • Condition: Prader-Willi Syndrome
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Growth Hormone Treatment
  • Number of Patients: 43
  • Published —
The study researched the outcomes of growth hormone treatment for adults with Prader-Willi syndrome.
  • Condition: Obese Adolescent with Prader-Willi Syndrome (PWS)
  • Journal: International journal of environmental research and public health
  • Treatment Used: Exercise Training
  • Number of Patients: 14
  • Published —
This study compared an exercise training program in an obese adolescent with Prader-Willi syndrome (genetic disorder; PWS) versus other obese adolescents.
  • Condition: Obstructive Sleep Apnea in Children with Prader-Willi Syndrome
  • Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • Treatment Used: Adenotonsillectomy
  • Number of Patients: 41
  • Published —
The study researched the effects of adenotonsillectomy for treating obstructive sleep apnea in children with Prader-Willi syndrome.
  • Condition: Temper outbursts in adults with Prader-Willi Syndrome
  • Journal: PloS one
  • Treatment Used: Transcutaneous vagus nerve stimulation
  • Number of Patients: 5
  • Published —
The aim of the study was to determine the effects of transcutaneous vagus nerve stimulation for temper outbursts in adults with Prader-Willi Syndrome.
  • Condition: Prader-Willi Syndrome
  • Journal: Translational psychiatry
  • Treatment Used: Topiramate
  • Number of Patients: 62
  • Published —
In this study, researchers evaluated the effects of topiramate on the behavior of persons with Prader-Willi syndrome.
  • Condition: Sleep Disordered Breathing (SDB) in Patients with Silver-Russell Syndrome (SRS)
  • Journal: Sleep medicine
  • Treatment Used: Recombinant Growth Hormone (rGH) Therapy
  • Number of Patients: 34
  • Published —
This study characterized sleep in children with Silver-Russell syndrome (SRS) and evaluated the impact of recombinant growth hormone (rGH) therapy.
  • Condition: Infants or Toddlers with Prader-Willi Syndrome (PWS)
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Recombinant Human Growth Hormone (rhGHO)
  • Number of Patients: 34
  • Published —
This study evaluated the safety of recombinant human growth hormone (rhGH) (Eutropin, LG Chem, Ltd.) and its effectiveness on growth, body composition, and motor and cognitive development in infants and toddlers with Prader-Willi syndrome (PWS) compared with a comparator treatment (Genotropin, Pfizer, Inc.).
  • Condition: Pediatric Patients with Prader-Willi Syndrome (PWS)
  • Journal: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
  • Treatment Used: Recombinant Human Growth Hormone (rhGH)
  • Number of Patients: 215
  • Published —
This study evaluated the proper recombinant human growth hormone (rhGH) does in pediatric patients with Prader-Willi syndrome (genetic disorder; PWS).
  • Condition: Children with Growth Hormone Deficiency in the United States and Europe
  • Journal: The Journal of clinical endocrinology and metabolism
  • Treatment Used: Growth Hormone (Norditropin)
  • Number of Patients: 19847
  • Published —
This review of the literature assessed real-world effectiveness and safety of growth hormone (GH; Norditropin) and compared clinical characteristics of growth hormone-treated children in the United States and Europe.
  • Condition: Infants with Prader-Willi Syndrome (PWS) Younger Than 2 Years
  • Journal: Journal of pediatric endocrinology & metabolism : JPEM
  • Treatment Used: Growth Hormone (GH) Therapy
  • Number of Patients: 14
  • Published —
This study assessed the safety of growth hormone (GH) therapy in infants younger than 2 years of age with Prader-Willi syndrome (PWS).
Showing 1-12 of 20